BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 32766812)

  • 1. Plasma Chemokines Are Baseline Predictors of Unfavorable Treatment Outcomes in Pulmonary Tuberculosis.
    Kumar NP; Moideen K; Nancy A; Viswanathan V; Thiruvengadam K; Nair D; Banurekha VV; Sivakumar S; Hissar S; Kornfeld H; Babu S
    Clin Infect Dis; 2021 Nov; 73(9):e3419-e3427. PubMed ID: 32766812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Plasma Matrix Metalloproteinase and Tissue Inhibitors of Matrix Metalloproteinase Levels With Adverse Treatment Outcomes Among Patients With Pulmonary Tuberculosis.
    Kumar NP; Moideen K; Nancy A; Viswanathan V; Thiruvengadam K; Sivakumar S; Hissar S; Nair D; Banurekha VV; Kornfeld H; Babu S
    JAMA Netw Open; 2020 Dec; 3(12):e2027754. PubMed ID: 33258908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma chemokines are biomarkers of disease severity, higher bacterial burden and delayed sputum culture conversion in pulmonary tuberculosis.
    Kumar NP; Moideen K; Nancy A; Viswanathan V; Shruthi BS; Sivakumar S; Natarajan M; Kornfeld H; Babu S
    Sci Rep; 2019 Dec; 9(1):18217. PubMed ID: 31796883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chitinase and indoleamine 2, 3-dioxygenase are prognostic biomarkers for unfavorable treatment outcomes in pulmonary tuberculosis.
    Kumar NP; Nancy A; Viswanathan V; Sivakumar S; Thiruvengadam K; Ahamed SF; Hissar S; Kornfeld H; Babu S
    Front Immunol; 2023; 14():1093640. PubMed ID: 36814914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Host Blood RNA Transcript and Protein Signatures for Sputum-Independent Diagnostics of Tuberculosis in Adults.
    Sivakumaran D; Ritz C; Gjøen JE; Vaz M; Selvam S; Ottenhoff THM; Doherty TM; Jenum S; Grewal HMS
    Front Immunol; 2020; 11():626049. PubMed ID: 33613569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heightened Microbial Translocation Is a Prognostic Biomarker of Recurrent Tuberculosis.
    Kumar NP; Moideen K; Viswanathan V; Sivakumar S; Ahamed SF; Ponnuraja C; Hissar S; Kornfeld H; Babu S
    Clin Infect Dis; 2022 Nov; 75(10):1820-1826. PubMed ID: 35352112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma chemokines as immune biomarkers for diagnosis of pediatric tuberculosis.
    Kumar NP; Hissar S; Thiruvengadam K; Banurekha VV; Balaji S; Elilarasi S; Gomathi NS; Ganesh J; Aravind MA; Baskaran D; Tripathy S; Swaminathan S; Babu S
    BMC Infect Dis; 2021 Oct; 21(1):1055. PubMed ID: 34635070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for tuberculosis smear non-conversion in Eden district, Western Cape, South Africa, 2007-2013: a retrospective cohort study.
    Mlotshwa M; Abraham N; Beery M; Williams S; Smit S; Uys M; Reddy C; Medina-Marino A
    BMC Infect Dis; 2016 Aug; 16():365. PubMed ID: 27484399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlates of treatment outcomes and drug resistance among pulmonary tuberculosis patients attending tertiary care hospitals of Kolkata, India.
    Goswami A; Chakraborty U; Mahapatra T; Mahapatra S; Mukherjee T; Das S; Das A; Dey SK; Ray S; Bhattacharya B; Pal NK
    PLoS One; 2014; 9(10):e109563. PubMed ID: 25289974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recurrence of tuberculosis among newly diagnosed sputum positive pulmonary tuberculosis patients treated under the Revised National Tuberculosis Control Programme, India: A multi-centric prospective study.
    Velayutham B; Chadha VK; Singla N; Narang P; Gangadhar Rao V; Nair S; Ramalingam S; Narayanan Sivaramakrishnan G; Joseph B; Selvaraju S; Shanmugam S; Narang R; Pachikkaran P; Bhat J; Ponnuraja C; Bajaj Bhalla B; Shivashankara BA; Sebastian G; Yadav R; Kumar Sharma R; Sarin R; Myneedu VP; Singla R; Khayyam K; Mrithunjayan SK; Jayasankar SP; Sanker P; Viswanathan K; Viswambharan R; Mathuria K; Bhalla M; Singh N; Tumane KB; Dawale A; Tiwari CP; Bansod R; Jayabal L; Murali L; Khaparde SD; Rao R; Jawahar MS; Natrajan M
    PLoS One; 2018; 13(7):e0200150. PubMed ID: 29979738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CCL2 responses to Mycobacterium tuberculosis are associated with disease severity in tuberculosis.
    Hasan Z; Cliff JM; Dockrell HM; Jamil B; Irfan M; Ashraf M; Hussain R
    PLoS One; 2009 Dec; 4(12):e8459. PubMed ID: 20041183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sputum conversion at the end of intensive phase of Category-1 regimen in the treatment of pulmonary tuberculosis patients with diabetes mellitus or HIV infection: An analysis of risk factors.
    Banu Rekha VV; Balasubramanian R; Swaminathan S; Ramachandran R; Rahman F; Sundaram V; Thyagarajan K; Selvakumar N; Adhilakshmi AR; Iliayas S; Narayanan PR
    Indian J Med Res; 2007 Nov; 126(5):452-8. PubMed ID: 18160750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and Incidence of Smear-Positive Pulmonary Tuberculosis in the Hetosa District of Arsi Zone, Oromia Regional State of Central Ethiopia.
    Hamusse S; Demissie M; Teshome D; Hassen MS; Lindtjørn B
    BMC Infect Dis; 2017 Mar; 17(1):214. PubMed ID: 28302070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of Anaemia and Magnesium Levels at the Initiation of Tuberculosis Therapy with Sputum Conversion among Pulmonary Tuberculosis Patients.
    Agrawal Y; Goyal V; Singh A; Lal S
    J Clin Diagn Res; 2017 Jun; 11(6):BC01-BC04. PubMed ID: 28764146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute Phase Proteins Are Baseline Predictors of Tuberculosis Treatment Failure.
    Kumar NP; Moideen K; Nancy A; Viswanathan V; Thiruvengadam K; Sivakumar S; Hissar S; Kornfeld H; Babu S
    Front Immunol; 2021; 12():731878. PubMed ID: 34867953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low body mass index is associated with diminished plasma cytokines and chemokines in both active and latent tuberculosis.
    Kumar NP; Nancy AP; Moideen K; Menon PA; Banurekha VV; Nair D; Nott S; Babu S
    Front Nutr; 2023; 10():1194682. PubMed ID: 37324745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipoarabinomannan in sputum to detect bacterial load and treatment response in patients with pulmonary tuberculosis: Analytic validation and evaluation in two cohorts.
    Kawasaki M; Echiverri C; Raymond L; Cadena E; Reside E; Gler MT; Oda T; Ito R; Higashiyama R; Katsuragi K; Liu Y
    PLoS Med; 2019 Apr; 16(4):e1002780. PubMed ID: 30978194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of vitamin D3 on chemokine expression in pulmonary tuberculosis.
    Selvaraj P; Harishankar M; Singh B; Banurekha VV; Jawahar MS
    Cytokine; 2012 Oct; 60(1):212-9. PubMed ID: 22800603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical diagnostic performance of the simultaneous amplification and testing methods for detection of the Mycobacterium tuberculosis complex for smear-negative or sputum-scarce pulmonary tuberculosis in China.
    Fan L; Zhang Q; Cheng L; Liu Z; Ji X; Cui Z; Ju J; Xiao H
    Chin Med J (Engl); 2014; 127(10):1863-7. PubMed ID: 24824246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Novel Reading Scheme for Assessing the Extent of Radiographic Abnormalities and Its Association with Disease Severity in Sputum Smear-Positive Tuberculosis: An Observational Study in Hyderabad/India.
    Grozdanovic Z; Berrocal Almanza LC; Goyal S; Hussain A; Klassert TE; Driesch D; Tokaryeva V; Löschmann YY; Sumanlatha G; Ahmed N; Valluri V; Schumann RR; Lala B; Slevogt H
    PLoS One; 2015; 10(9):e0138070. PubMed ID: 26381644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.